This 2015 double-blind, randomized, placebo-controlled pilot study evaluated the efficacy of a probiotic consortium (Lab4) combined with vitamin C in preventing respiratory tract infections (RTIs) among 69 healthy preschool children aged 3–6 years. Over six months, children received either a daily dose of 1.25 × 10¹⁰ CFU of specific Lactobacillus
